At Cerba Research, we develop, validate, qualify and implement assays on a global scale. With flow cytometry  capacity and capabilities in Belgium, the United States, Australia, China and Taiwan, we are a leading central lab known for our expertise. Our network develops and validates drug-specific panels aligned with your needs. From client conversations to centralized data analysis and review, our global team is dedicated to meeting your target timeline. 

Which Flow Cytometry instruments are present in our laboratories worldwide?

• BD FACS Canto: present in laboratories in USA, Belgium, and China 
• BD FACS Lyrics: present in laboratories in USA, Belgium, Australia, and Taiwan 
• Cytek Aurora in laboratories in USA and Belgium 

With our spectral flow cytometry capabilities, we simultaneously characterize cellular populations from the same tube with a complete set of data from the sample, all while reducing the time of sample acquisition. 

Cerba Research is proud to answer your  exploratory needs for clinical trials and retrospective analysis with our  state of art instruments and high quality data output. 

Flow cytometry plays a crucial role in the production process of CAR+ T cells, where it is used for assessing transduction efficiency, purity, and characterization of the CAR+ T product before infusion. After manufacturing, when CAR+ T cells are infused into the patients, flow cytometry is used again in clinical laboratories to assess CAR+ T expansion, efficiency, and persistence and to monitor minimal residual disease (MRD).

In our CAR+T Drug Development ebook, Ans De Beuckelaer, Regional Head Flow Cytometry EU, and Rowan Claeys, Clinical Biologist at Cerba Research, dive deeper into key elements of flow cytometry:

• The importance of flow cytometry in Car+T clinical research and its uses
• Key aspects in developing a CAR+ T trial
• The added value of flow cytometry in multiple myeloma, Minimal Residual Disease (MRD) assessments, and multiple myeloma phenotype
• Car+T-cell Therapy: patient treatment, targeted antigens and solutions for MRD assessments and multiple myeloma phenotype assessment.

Among the techniques of biomarker analysis, there is flow cytometry, which allows for precise analysis of liquid samples, as well as other applications. For more information, watch the Advantages and Versatility of Flow Cytometry Considerations webinar.